1,721,020 research outputs found
Pharmacokinetics and inotropic effects of Gitoformate in normal subjects and in patients with congestive heart failure
No full textAnalisi tomografica con tallio-201 della perfusione miocardica in pazienti asintomatici con lupus eritematoso sistemico
No full text
Analisi tomografica con tallio-201 della perfusione miocardica in pazienti asintomatici con lupus eritematoso sistemico
No full textAnalysis of the exercise induced changes of the atrial vectorcardiogram in mitral valve stenosis by means of electronic elaborator
No full textThallium-201 myocardial perfusion imaging after aortocoronary bypass surgery in patients treated with sulodexide versus patients treated with ASA-dipyridamole
No full textThe aim of this investigation was to compare the preventive effect of sulodexide, a glycosaminoglycan drug, tested versus ASA-dipyridamole association, on the occlusion of venous aortocoronary bypass. A group A of 23 patients, for a total of 22 anastomosis with internal mammary artery and 46 venous bypass, was treated with sulodexide 500 USL/day. A group B of 18 patients for a total of 19 anastomosis with internal mammary artery and 33 venous bypass, was treated with ASA-dipyridamole 300 mg + 400 mg/day. Three and 9 months after surgery, all patients underwent thallium-201 myocardial perfusion imaging, associated with ergometric test. At the first control after 3 months, reversible perfusion defect in one or more myocardial segments was observed in 8 patients of group A and 3 patients of group B (2 A patients and 1 B patient in non revascularized myocardial segments); after 9 months, reversible perfusion defects were observed in 4 A patients and in 4 B patients. After 3 months, non reversible perfusion defect imaging in non infarcted myocardial segments was observed in 2 A patients and in 1 B patient; after 9 months, in 1 patient of both groups. This research shows higher incidence, at first control after 3 months, of ischemic reversible perfusion defects in patients treated with sulodexide, with an evident improvement in some patients recontrolled after 9 months. At the last control after 9 months, the scintigraphic findings showed similar evidence of perfusion defects in both groups treated with sulodexide or ASA-dipyridamole, with concordant angiographic findings (78.6%). Our preliminary results are encouraging and suggest further widespread studies on sulodexide therapy
La funzione ventricolare sinistra a riposo e durante sforzo nei pazienti con diabete mellito insulino-dipendente in buon compenso stabile nel tempo.
No full text
Plasma levels of various formulations of oral digoxin, and correlated indices of myocardial function in the healthy subject and in the decompensated patient]
No full text
- …
